[Mortality and causes of death among intravenous drug addicts in Oslo].
In order to study mortality and causes of death among intravenous drug users in Oslo, 1,009 (829 HIV negative and 180 HIV positive) intravenous drug users were followed from their first HIV test for a mean period of 36 months (range 1-67 months). 87 (55 HIV negatives and 32 HIV positives) died during the follow-up period. Compared with the general population with the same age and sex distribution, the relative risk of death for the intravenous drug users was 31. 4% of the HIV negatives (38/829) and 11% of the HIV positives (20/180) died from drug overdose during the follow-up period. 2% of the HIV positives and 0.4% of the total cohort (4/1,009) died from AIDS. Drug overdose represented the major threat to life among intravenous drug users in this study. Due to the dynamic of the HIV epidemic, AIDS may gain an increasing impact on mortality. However, in order to forecast the number of AIDS cases among intravenous drug users, it is necessary to control for the high non-AIDS related mortality.
Eskild
A
A
Seksjon for epidemiologi, Statens Institutt for Folkehelse, Oslo.
Magnus
P
P
Samuelsen
S O
SO
Sohlberg
C
C
Kittelsen
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality / Q000635:transmission; D000293:Adolescent; D000328:Adult; D002423:Cause of Death; D062787:Drug Overdose; D005260:Female; D005500:Follow-Up Studies; D006679:HIV Seropositivity / Q000401:mortality; D006801:Humans; D008297:Male; D009664:Norway / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000401:mortality*
Dødelighet og dødsårsaker blant intravenøse stoffmisbrukere i Oslo.